Susquehanna International Group
TTPH

Susquehanna International Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Susquehanna International Group’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,135
Closed -$173K – 10428
2018
Q3 		$173K Sell
3,135
-6,755
-68% -$431K ﹤0.01% 8331
2018
Q2 		$706K Sell
9,890
-840
-8% -$59.3K ﹤0.01% 6115
2018
Q1 		$659K Buy
10,730
+5,350
+99% +$470K ﹤0.01% 6087
2017
Q4 		$678K Sell
5,380
-375
-7% -$48K ﹤0.01% 6020
2017
Q3 		$787K Sell
5,755
-8,290
-59% -$1.11M ﹤0.01% 5715
2017
Q2 		$2M Buy
14,045
+8,045
+134% +$1.24M ﹤0.01% 3908
2017
Q1 		$1.1M Buy
6,000
+4,635
+340% +$520K ﹤0.01% 4917
2016
Q4 		$110K Sell
1,365
-2,100
-61% -$166K ﹤0.01% 9037
2016
Q3 		$265K Buy
3,465
+2,595
+298% +$208K ﹤0.01% 7135
2016
Q2 		$75K Sell
870
-1,015
-54% -$93K ﹤0.01% 8145
2016
Q1 		$175K Sell
1,885
-1,685
-47% -$168K ﹤0.01% 8083
2015
Q4 		$716K Buy
3,570
+835
+31% +$167K ﹤0.01% 6098
2015
Q3 		$408K Sell
2,735
-490
-15% -$360K ﹤0.01% 7504
2015
Q2 		$3.06M Buy
3,225
+705
+28% +$576K ﹤0.01% 3808
2015
Q1 		$1.85M Sell
2,520
-470
-16% -$353K ﹤0.01% 4471
2014
Q4 		$2.38M Buy
2,990
+170
+6% +$91.5K ﹤0.01% 4127
2014
Q3 		$1.13M Buy
2,820
+1,790
+174% +$479K ﹤0.01% 5712
2014
Q2 		$278K Buy
+1,030
New +$221K ﹤0.01% 8515

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Susquehanna International Group's TTPH Position: Q2 2019 in Review

Susquehanna International Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 1,168 shares — an estimated $31K sold.

Susquehanna International Group first reported a position in TTPH in Q2 2013 and held it in 17 quarters. The position peaked at $4.2M in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • Susquehanna International Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 1,168 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $31K.
  • Susquehanna International Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
  • Susquehanna International Group's Tetraphase Pharmaceuticals, Inc. position peaked at $4.2M in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.